Outset Medical Launches Inaugural ESG Report | News | bakersfield.com The Bakersfield CalifornianOutset Medical Launches Inaugural ESG Report | News | bakersfield.com The Bakersfield Californian
Impact Investing Forum 2022
London. Dec 07-08, 2022.
SAN JOSE, Calif BUSINESS WIIRE)–Nov 8, 20,21–Outset Medical, Inc., (Nasdaq OM: OM) (“Outset”), a pioneering medical technology company, today released its inaugural Environmental, Social, and Governance report. This report highlights its ESG-related programs, priorities, goals, and performances. “Our ESG journey at Outset is rooted in our mission of catalyzing permanent and profound change in how, where, and when dialysis is delivered to lower cost and restore identity and agency to patients,” stated Leslie Trigg (President and Chief Executive Officer). We are committed to patients and providers and will continue to innovate a dialysis delivery system and equipment that hasn’t changed in decades. This is consistent with our focus on operating responsibly, sustainably and transparently. Our inaugural ESG Report provides insight into the important results we have achieved so far and how we plan on building on that momentum. “Outset’s first year of being a public company was marked by notable ESG achievements. These include: Raising awareness about patient disparities in kidney care
Outset has been a major advocate for patient-centric policies that improve the lives and quality of life for dialysis patients. This is especially important considering COVID-19’s disparate effect on people of color and people with end stage renal disease. We are working with top patient-focused organizations to increase access to home healthcare, drive better outcomes and help eliminate racial disparities when it comes to kidney patients using home dialysis.
Outset’s Board is composed of more women than men. This composition puts us in a select group that is leading the way in closing the gender gap within corporate boardrooms. We plan to push even further to set a new standard in diversity, equity and inclusion.
When we built our OMM manufacturing plant, environmental sustainability was a major focus. This included water conservation and recycling, energy efficiency and waste management. In our first year of operation, we set ambitious water recycling goals that were exceeded by our employees. We set ambitious workplace goals and exceeded them in our first year of operation. The report addresses specific standards defined by the Sustainability Accounting Standards Board (SASB) for the Medical Equipment and Supplies industry, and includes an index with relevant SASB disclosures.To view Outset’s ESG report, please visit the ESG section of the Company’s investor relations website: http://investors.outsetmedical.com/environmental-social-and-governanceAbout Outset Medical, Inc.Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The FDA-approved Tablo(R) Hemodialysis System is a significant technological breakthrough that transforms dialysis for patients and simplifies operations for providers. Tablo is a single enterprise solution that can easily be used across the continuum. It allows dialysis to be delivered anywhere, anytime and by anyone. Tablo can be used as a mobile dialysis clinic with water purification and on demand dialysate production. It also has 2-way wireless data transmission and a proprietary analytics platform that enables a holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc. Forward-Looking StatementsThis release may contain forward-looking statement within the meaning of Section 27A of Securities Act of 1933, as modified, and Section 21E of Securities Exchange Act of 1934, amended. These statements include statements about Outset’s future compliance and sustainability initiatives, expected environmental, social and governance policies and practices, as well as other plans, prospects and goals, strategies, or future actions. Forward-looking statements are subject to risks and uncertainties. Some of these risks cannot be predicted or quantified and could cause actual results or other events to differ materially. These risks and uncertainties include those described in Outset’s most recent annual Form 10-K and Quarterly Form 10-Q reports filed with the U.S Securities and Exchange Commission. These forward-looking statements are only current as of the date hereof. They should not be relied upon. Outset disclaims any obligation to update these forward-looking statements.View source version on businesswire.com:https://www.businesswire.com/news/home/20211108005227/en/CONTACT: Investor ContactLynn Lewis or Brian JohnstonGilmartin Groupinvestors@outsetmedical.comMedia ContactNicole ShannonDirector, Marketing Communications for Outset Medicalnshannon@outsetmedical.comKEYWORD: UNITED STATES NORTH AMERICA CALIFORNIAINDUSTRY KEYWORD: MEDICAL DEVICES HEALTHSOURCE: Outset Medical, Inc.Copyright Business Wire 2021.PUB: 11/08/2021 08:00 AM/DISC: 11/08/2021 08:02 AMhttp://www.businesswire.com/news/home/20211108005227/en
Positive Cases Among Kern Residents: 151,432Deaths: 1,706Recovered and Presumed Recovered Residents: 141,346Percentage of all cases that are unvaccinated: 95.2Percentage of all hospitalizations that are unvaccinated: 95.73Updated: 11/5/2021. Source: Kern County Public Health Services DepartmentMore Coronavirus coverage